$PRLB

WEHRWEIN SVEN sold $39K of PRLB

WEHRWEIN SVEN sold 500 shares of Proto Labs Inc (PRLB) at $78.38 on 2026-06-02.

Original reporting
SEC EDGAR · WEHRWEIN SVEN
Published Jun 4, 2026, 8:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PRLB
Neutral
medium confidence
Mentioned
$PRLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRLBNeutralLow
01

Why it matters

The disclosure updates the insider-trading record with a specific open-market sale price and post-transaction holdings, which can marginally influence sentiment but is not a standalone fundamental event.

02

Market read

Traders may use the sale as a sentiment datapoint, but without additional company-specific catalysts it is unlikely to materially change valuation expectations.

03

What to watch

Transaction size (500 shares) and lack of a 10b5-1 plan context can reduce interpretability; compare with prior insider activity and any concurrent company news.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-04; sale executed 2026-06-02.

Background

The article is an SEC Form 4 insider transaction disclosure for Proto Labs (PRLB).

Company-level read

Ticker impact

$PRLBNeutralMedium confidence
Context

Proto Labs director WEHRWEIN SVEN sold 500 shares in an open-market transaction at $78.38 on 2026-06-02, disclosed via Form 4.

Expected impact

Likely limited near-term impact; watch for follow-on insider activity or other catalysts.

Evidence & confidence

The filing provides a specific sale price/date and size, but insider transactions alone rarely drive sustained repricing without corroborating news.

Market effects

No clear sector read-through from a single director’s small sale.

None.

None.

Counterpoint

A non-10b5-1 sale can be driven by diversification/tax needs rather than bearish expectations, so the signal may be overstated.

Key entities

  • Proto Labs Inc

    Subject of the Form 4 insider transaction disclosure.

  • WEHRWEIN SVEN

    Director who sold 500 shares of PRLB.

Related articles

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.

$PRLBMedAI 8/10

Protolab Shares Up As Q2 Profit Rises, Lifts FY26 Outlook - Update

Protolabs (PRLB) shares rose about 3.3% to $77.64 after the company reported Q2 net income of $9.15 million, up from $4.43 million a year earlier, with revenue at $149.34 million. Protolabs raised its FY2026 revenue growth outlook to 8% to 10% and issued Q3 guidance of $145 million to $153 million revenue and EPS of $0.34 to $0.42.

$PRLBMedAI 8/10

Proto Labs: Q2 Earnings Snapshot

Proto Labs Inc. (PRLB) reported Q2 profit of $9.2 million, or 37 cents per share. Adjusted earnings were 60 cents per share, and revenue was $149.3 million. For the quarter ending September, the company forecast 56 to 64 cents per share. For fiscal Q3, it expects revenue of $145 million to $153 million.

$PRLBHigh

Proto Labs Inc (PRLB): Results of Operations and Financial Condition

Proto Labs Inc (PRLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prlb-2026731xexx991.htm EX-99.1 Document Exhibit 99.1 Protolabs Reports Financial Results for the Second Quarter of 2026 Record Quarterly Revenue of $149.3 Million, a 10.6% Increase Year-Over-Year GAAP Earnings Per Share of $0.37, Non-GAAP Earnings Per Share of $0.60 Ra